Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxycodone/naloxone prolonged-release tablets versus oxycodone prolonged-release tablets for chronic cancer pain with constipation assessment
2007-001313-42Phase 2Completed
- Sponsor
- Mundipharma Research
- Start
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of oxycodone + naloxone and oxycodone in cancer pain (2 arms), sponsored by Mundipharma Research. Primary endpoints: Bowel Function Index and Laxative use. Started Jun 2007; status: completed.
02
Drugs
oxycodone + naloxoneoxycodone
03
Conditions
cancer pain
Beyond the preview
Go deeper on 2007-001313-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001313-42.